FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2626916804> ?p ?o ?g. }

• W2626916804 endingPage "987" @default.
• W2626916804 startingPage "980" @default.
• W2626916804 abstract "Background & AimsLow activity of natural killer (NK) cells has been associated with increased risk of cancer and has been reported in patients with colorectal cancer (CRC). Activity of NK cells can be measured in a small volume of whole blood by a commercially available test. We investigated whether this test could be used to identify patients with CRC, using findings from colonoscopy as a reference standard.MethodsWe performed an open-label, prospective, cross-sectional study of 872 high-risk subjects (more than 40 years old) screened for CRC by colonoscopy at a university hospital in Montreal, Canada from October 2014 through January 2016. Blood samples were collected on the day of colonoscopy, prior to the procedure. The test involves stimulation of whole blood with cytokine that induces NK cells to secrete interferon gamma (IFNG), which is quantified by an ELISA. Tissue samples were taken from lesions during the colonoscopy and analyzed histologically; subjects were classified as having no evidence of disease, adenomatous polyps of less than 10 mm, of 10 mm or more, or CRC. We used the non-parametric Mann-Whitney test to compare NK cell activity between subjects with no evidence of CRC and subjects found to have CRC. Receiver operating characteristic curve analysis was used to assess the ability of the test to identify individuals with CRC. The primary objective was to determine the difference in NK cell activity between subjects with vs without CRC. The secondary objective was the test performance, based on receiver operating characteristic analysis, and cut-off value that most accurately identified individuals with CRC.ResultsWe found a significant difference in NK cell activity between the 23 subjects with CRC (based on pathology analysis) and the 849 subjects without CRC: subjects found to have CRC by colonoscopy had a median level of 86.0 pg IFNG/mL (inter-quartile range, 43.3–151.0 pg IFNG/mL), whereas subjects without CRC had a median level of 298.1 pg IFNG/mL (inter-quartile range, 100.4–920.2 pg IFNG/mL) (P = .0002). The cut-off value that most accurately identified subjects with CRC was 181 pg/mL. The NK cell activity test identified subjects with CRC with 87.0% sensitivity, 60.8% specificity, a positive predictive value of 5.7%, and a negative predictive value of 99.4%. The odds ratio for detection of CRC in subjects with low NK cell activity vs subjects with higher NK cell activity was 10.3 (95% CI, 3.03–34.9).ConclusionsUsing colonoscopy as the reference standard, a test for NK cell activity in whole blood samples identified patients with CRC with 87.0% sensitivity and a negative predictive value of 99.4%. Subjects with low NK cell activity had a 10-fold higher risk of CRC compared with subjects with high NK cell activity. This test might be used in clinical practice to assess patients for risk of CRC. Clinicaltrials.gov number: NCT02291198. Low activity of natural killer (NK) cells has been associated with increased risk of cancer and has been reported in patients with colorectal cancer (CRC). Activity of NK cells can be measured in a small volume of whole blood by a commercially available test. We investigated whether this test could be used to identify patients with CRC, using findings from colonoscopy as a reference standard. We performed an open-label, prospective, cross-sectional study of 872 high-risk subjects (more than 40 years old) screened for CRC by colonoscopy at a university hospital in Montreal, Canada from October 2014 through January 2016. Blood samples were collected on the day of colonoscopy, prior to the procedure. The test involves stimulation of whole blood with cytokine that induces NK cells to secrete interferon gamma (IFNG), which is quantified by an ELISA. Tissue samples were taken from lesions during the colonoscopy and analyzed histologically; subjects were classified as having no evidence of disease, adenomatous polyps of less than 10 mm, of 10 mm or more, or CRC. We used the non-parametric Mann-Whitney test to compare NK cell activity between subjects with no evidence of CRC and subjects found to have CRC. Receiver operating characteristic curve analysis was used to assess the ability of the test to identify individuals with CRC. The primary objective was to determine the difference in NK cell activity between subjects with vs without CRC. The secondary objective was the test performance, based on receiver operating characteristic analysis, and cut-off value that most accurately identified individuals with CRC. We found a significant difference in NK cell activity between the 23 subjects with CRC (based on pathology analysis) and the 849 subjects without CRC: subjects found to have CRC by colonoscopy had a median level of 86.0 pg IFNG/mL (inter-quartile range, 43.3–151.0 pg IFNG/mL), whereas subjects without CRC had a median level of 298.1 pg IFNG/mL (inter-quartile range, 100.4–920.2 pg IFNG/mL) (P = .0002). The cut-off value that most accurately identified subjects with CRC was 181 pg/mL. The NK cell activity test identified subjects with CRC with 87.0% sensitivity, 60.8% specificity, a positive predictive value of 5.7%, and a negative predictive value of 99.4%. The odds ratio for detection of CRC in subjects with low NK cell activity vs subjects with higher NK cell activity was 10.3 (95% CI, 3.03–34.9). Using colonoscopy as the reference standard, a test for NK cell activity in whole blood samples identified patients with CRC with 87.0% sensitivity and a negative predictive value of 99.4%. Subjects with low NK cell activity had a 10-fold higher risk of CRC compared with subjects with high NK cell activity. This test might be used in clinical practice to assess patients for risk of CRC. Clinicaltrials.gov number: NCT02291198." @default.
• W2626916804 created "2017-06-23" @default.
• W2626916804 creator A5030162379 @default.
• W2626916804 creator A5040536252 @default.
• W2626916804 creator A5091844714 @default.
• W2626916804 date "2017-10-01" @default.
• W2626916804 modified "2023-10-10" @default.
• W2626916804 title "Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy" @default.
• W2626916804 cites W1483194800 @default.
• W2626916804 cites W1517515708 @default.
• W2626916804 cites W1997849135 @default.
• W2626916804 cites W2007731295 @default.
• W2626916804 cites W2018120089 @default.
• W2626916804 cites W2019069555 @default.
• W2626916804 cites W2019813857 @default.
• W2626916804 cites W2020973179 @default.
• W2626916804 cites W2033128870 @default.
• W2626916804 cites W2041100743 @default.
• W2626916804 cites W2075464097 @default.
• W2626916804 cites W2076617145 @default.
• W2626916804 cites W2138053507 @default.
• W2626916804 cites W2140512658 @default.
• W2626916804 doi "https://doi.org/10.1053/j.gastro.2017.06.009" @default.
• W2626916804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28625834" @default.
• W2626916804 hasPublicationYear "2017" @default.
• W2626916804 type Work @default.
• W2626916804 sameAs 2626916804 @default.
• W2626916804 citedByCount "67" @default.
• W2626916804 countsByYear W26269168042018 @default.
• W2626916804 countsByYear W26269168042019 @default.
• W2626916804 countsByYear W26269168042020 @default.
• W2626916804 countsByYear W26269168042021 @default.
• W2626916804 countsByYear W26269168042022 @default.
• W2626916804 countsByYear W26269168042023 @default.
• W2626916804 crossrefType "journal-article" @default.
• W2626916804 hasAuthorship W2626916804A5030162379 @default.
• W2626916804 hasAuthorship W2626916804A5040536252 @default.
• W2626916804 hasAuthorship W2626916804A5091844714 @default.
• W2626916804 hasConcept C121608353 @default.
• W2626916804 hasConcept C126322002 @default.
• W2626916804 hasConcept C12868164 @default.
• W2626916804 hasConcept C143998085 @default.
• W2626916804 hasConcept C2778435480 @default.
• W2626916804 hasConcept C2779599708 @default.
• W2626916804 hasConcept C526805850 @default.
• W2626916804 hasConcept C71924100 @default.
• W2626916804 hasConcept C90924648 @default.
• W2626916804 hasConceptScore W2626916804C121608353 @default.
• W2626916804 hasConceptScore W2626916804C126322002 @default.
• W2626916804 hasConceptScore W2626916804C12868164 @default.
• W2626916804 hasConceptScore W2626916804C143998085 @default.
• W2626916804 hasConceptScore W2626916804C2778435480 @default.
• W2626916804 hasConceptScore W2626916804C2779599708 @default.
• W2626916804 hasConceptScore W2626916804C526805850 @default.
• W2626916804 hasConceptScore W2626916804C71924100 @default.
• W2626916804 hasConceptScore W2626916804C90924648 @default.
• W2626916804 hasIssue "4" @default.
• W2626916804 hasLocation W26269168041 @default.
• W2626916804 hasLocation W26269168042 @default.
• W2626916804 hasOpenAccess W2626916804 @default.
• W2626916804 hasPrimaryLocation W26269168041 @default.
• W2626916804 hasRelatedWork W2006998504 @default.
• W2626916804 hasRelatedWork W2088704621 @default.
• W2626916804 hasRelatedWork W2343430176 @default.
• W2626916804 hasRelatedWork W2363227174 @default.
• W2626916804 hasRelatedWork W2381279477 @default.
• W2626916804 hasRelatedWork W2810418476 @default.
• W2626916804 hasRelatedWork W2999920852 @default.
• W2626916804 hasRelatedWork W3016587774 @default.
• W2626916804 hasRelatedWork W3028983594 @default.
• W2626916804 hasRelatedWork W3086230876 @default.
• W2626916804 hasVolume "153" @default.
• W2626916804 isParatext "false" @default.
• W2626916804 isRetracted "false" @default.
• W2626916804 magId "2626916804" @default.
• W2626916804 workType "article" @default.